首页> 外文期刊>Pediatric Hematology and Oncology >Second transplant for a thalassemia patient after graft rejection: with immunosuppression and allogeneic peripheral blood stem cell.
【24h】

Second transplant for a thalassemia patient after graft rejection: with immunosuppression and allogeneic peripheral blood stem cell.

机译:地中海贫血患者移植排斥后的第二次移植:具有免疫抑制作用和同种异体外周血干细胞。

获取原文
获取原文并翻译 | 示例
       

摘要

A 13-year old girl suffering from beta-thalassaemia major received bone marrow transplantation (BMT) from her HLA identical bother. After initial engraftment, she developed mixed chimerism. Secondary graft rejection occurred at 10 months after BMT and resulted in marrow aplasia. A second transplant with the same bone marrow donor was performed. The patient was conditioned with antithymocyte globulin 90 mg/kg followed by peripheral blood stem cell infusion. There was prompt engraftment and patient reverted to complete chimerism. There were no severe treatment-related complications or acute or chronic graft versus host disease after second transplant. The patient remained transfusion independent at 26 months after second transplant.
机译:一名患有β地中海贫血的13岁女孩因其HLA相同而受到了骨髓移植(BMT)的困扰。最初植入后,她发展了混合嵌合体。 BMT后10个月发生继发移植排斥反应,并导致骨髓发育不全。使用相同的骨髓供体进行第二次移植。患者接受90 mg / kg的抗胸腺细胞球蛋白调节,然后输注外周血干细胞。立即植入,患者恢复完全嵌合状态。第二次移植后没有严重的治疗相关并发症或急性或慢性移植物抗宿主病。在第二次移植后的26个月,患者保持独立于输血状态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号